Overview

Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)

Status:
Withdrawn
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This study intends to show the efficacy of remifentanil-dexmedetomidine infusions in combination with a caudal block for patients ages 1 year to 3 years old receiving elective surgery to investigate alternatives to the currently used volatile anesthetics.
Phase:
Phase 4
Details
Lead Sponsor:
Children's Research Institute
Mofya Diallo
Treatments:
Anesthetics
Dexmedetomidine
Remifentanil
Ropivacaine